Brought to you by 
Speedel files for, then withdraws IPO; lists shares on SWX
06 Feb 2006
Executive Summary
Speedel (cardiovascular and renal therapeutics) filed for its initial public offering last month but has since withdrawn it, citing poor market conditions. It had planned to trade on the Swiss Exchange after raising up to several hundred million Swiss francs.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com